lomustine has been researched along with Basal Ganglia Diseases in 1 studies
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pompili, A | 1 |
| Riccio, A | 1 |
| Jandolo, B | 1 |
| Fontana, M | 1 |
1 other study available for lomustine and Basal Ganglia Diseases
| Article | Year |
|---|---|
CCNU chemotherapy in adult patients with tumors of the basal ganglia and brain stem.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain Neoplasms; Brain Stem; Female; Humans; Lomust | 1980 |